UBS lowered the firm’s price target on Axon (AXON) to $610 from $840 and keeps a Neutral rating on the shares. Axon reported a “mixed” Q3, as orders disappointed but the outlook and business monument remain strong, the analyst tells investors in a research note.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AXON:
- Axon price target lowered to $753 from $893 at Piper Sandler
- Axon Enterprise: Strategic Expansion and Growth Prospects Make It a Buy Despite Recent Setbacks
- Axon price target lowered to $800 from $940 at Goldman Sachs
- Axon Enterprise Reports Strong Q3 2025 Growth
- Strong Growth Potential and Strategic Initiatives Drive Buy Rating for Axon Enterprise